These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20458558)

  • 1. Significance of estrogen receptor 1 (ESR-1) gene imbalances in colon and hepatocellular carcinomas based on tissue microarrays analysis.
    Tsiambas E; Georgiannos SN; Salemis N; Alexopoulou D; Lambropoulou S; Dimo B; Ioannidis I; Kravvaritis C; Karameris A; Patsouris E; Dourakis S
    Med Oncol; 2011 Dec; 28(4):934-40. PubMed ID: 20458558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromogenic in situ hybridization analysis of Epidermal Growth Factor Receptor gene/chromosome 7 numerical aberrations in hepatocellular carcinoma based on tissue microarrays.
    Tsiambas E; Manaios L; Papanikolopoulos C; Rigopoulos DN; Tsounis D; Karameris A; Soultati A; Koliopoulou A; Kravvaritis C; Sergentanis T; Patsouris E; Dourakis S
    Pathol Oncol Res; 2009 Sep; 15(3):511-20. PubMed ID: 19145479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG).
    Pentheroudakis G; Kotoula V; Eleftheraki AG; Tsolaki E; Wirtz RM; Kalogeras KT; Batistatou A; Bobos M; Dimopoulos MA; Timotheadou E; Gogas H; Christodoulou C; Papadopoulou K; Efstratiou I; Scopa CD; Papaspyrou I; Vlachodimitropoulos D; Linardou H; Samantas E; Pectasides D; Pavlidis N; Fountzilas G
    PLoS One; 2013; 8(7):e70634. PubMed ID: 23923010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulation of EGFR/VEGF/HIF-1a signaling pathway in colon adenocarcinoma based on tissue microarrays analysis.
    Rigopoulos DN; Tsiambas E; Lazaris AC; Kavantzas N; Papazachariou I; Kravvaritis C; Tsounis D; Koliopoulou A; Athanasiou AE; Karameris A; Manaios L; Sergentanis TN; Patsouris E
    J BUON; 2010; 15(1):107-15. PubMed ID: 20414936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of estrogen receptor alpha (ESR1) gene amplification in a series of breast cancers in Taiwan.
    Chen JR; Hsieh TY; Chen HY; Yeh KY; Chen KS; ChangChien YC; Pintye M; Chang LC; Hwang CC; Chien HP; Hsu YC
    Virchows Arch; 2014 Jun; 464(6):689-99. PubMed ID: 24756215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2/CHR 17 tissue microarray chromogenic in situ hybridization analysis in colon adenocarcinoma: multiple gene signals vs protein expression.
    Fotiades PP; Tsiambas E; Lazaris AC; Saetta AA; Karameris A; Vilaras G; Patsouris E
    J BUON; 2014; 19(1):109-14. PubMed ID: 24659651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2/neu expression and gene alterations in pancreatic ductal adenocarcinoma: a comparative immunohistochemistry and chromogenic in situ hybridization study based on tissue microarrays and computerized image analysis.
    Tsiambas E; Karameris A; Dervenis C; Lazaris AC; Giannakou N; Gerontopoulos K; Patsouris E
    JOP; 2006 May; 7(3):283-94. PubMed ID: 16685109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of CASP10 gene in colon, breast, lung and hepatocellular carcinomas.
    Oh JE; Kim MS; Ahn CH; Kim SS; Han JY; Lee SH; Yoo NJ
    Pathology; 2010 Jan; 42(1):73-6. PubMed ID: 20025484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-erb B2 (Her2/neu) is neither overexpressed nor amplified in hepatic neoplasms.
    Vlasoff DM; Baschinsky DY; De Young BR; Morrison CD; Nuovo GJ; Frankel WL
    Appl Immunohistochem Mol Morphol; 2002 Sep; 10(3):237-41. PubMed ID: 12373150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.
    Holst F; Stahl PR; Ruiz C; Hellwinkel O; Jehan Z; Wendland M; Lebeau A; Terracciano L; Al-Kuraya K; Jänicke F; Sauter G; Simon R
    Nat Genet; 2007 May; 39(5):655-60. PubMed ID: 17417639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene amplification of ESR1 in breast cancers--fact or fiction? A fluorescence in situ hybridization and multiplex ligation-dependent probe amplification study.
    Ooi A; Inokuchi M; Harada S; Inazawa J; Tajiri R; Kitamura SS; Ikeda H; Kawashima H; Dobashi Y
    J Pathol; 2012 May; 227(1):8-16. PubMed ID: 22170254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions.
    Lebeau A; Grob T; Holst F; Seyedi-Fazlollahi N; Moch H; Terracciano L; Turzynski A; Choschzick M; Sauter G; Simon R
    J Pathol; 2008 Oct; 216(2):151-7. PubMed ID: 18720455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study.
    Moelans CB; Monsuur HN; de Pinth JH; Radersma RD; de Weger RA; van Diest PJ
    Anal Cell Pathol (Amst); 2010; 33(1):13-8. PubMed ID: 20966540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of HER2 overexpression with gene amplification and its relation to chromosome 17 aneuploidy: a 5-year experience with invasive ductal and lobular carcinomas.
    Nassar A; Khoor A; Radhakrishnan R; Radhakrishnan A; Cohen C
    Int J Clin Exp Pathol; 2014; 7(9):6254-61. PubMed ID: 25337277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between different p53 expression patterns and chromosome 17 imbalances in pancreatic ductal adenocarcinoma based on tissue microarray analysis.
    Tsiambas E; Kravvaritis C; Tsounis D; Salemis NS; Niotis A; Niotis TH; Rigopoulos DN; Karameris A; Athanasiou AE; Patsouris E; Karakitsos P
    J BUON; 2010; 15(1):94-100. PubMed ID: 20414934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor overexpression/amplification in adenocarcinomas arising in the gastrointestinal tract.
    Rossi E; Villanacci V; Danesino C; Donato F; Nascimbeni R; Bassotti G
    Rev Esp Enferm Dig; 2011 Dec; 103(12):632-9. PubMed ID: 22217347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1).
    Najim O; Huizing M; Papadimitriou K; Trinh XB; Pauwels P; Goethals S; Zwaenepoel K; Peterson K; Weyler J; Altintas S; van Dam P; Tjalma W
    Cancer Treat Res Commun; 2019; 19():100123. PubMed ID: 30826563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation.
    Lin CH; Liu JM; Lu YS; Lan C; Lee WC; Kuo KT; Wang CC; Chang DY; Huang CS; Cheng AL
    J Clin Pathol; 2013 Feb; 66(2):140-5. PubMed ID: 23268322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.
    Chiang DY; Villanueva A; Hoshida Y; Peix J; Newell P; Minguez B; LeBlanc AC; Donovan DJ; Thung SN; Solé M; Tovar V; Alsinet C; Ramos AH; Barretina J; Roayaie S; Schwartz M; Waxman S; Bruix J; Mazzaferro V; Ligon AH; Najfeld V; Friedman SL; Sellers WR; Meyerson M; Llovet JM
    Cancer Res; 2008 Aug; 68(16):6779-88. PubMed ID: 18701503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.